Unknown

Dataset Information

0

The natural history of 21-hydroxylase autoantibodies in autoimmune Addison's disease.


ABSTRACT:

Background

The most common cause of primary adrenal failure (Addison's disease) in the Western world is autoimmunity characterized by autoantibodies against the steroidogenic enzyme 21-hydroxylase (CYP21A2, 21OH). Detection of 21OH-autoantibodies is currently used for aetiological diagnosis, but how levels of 21OH-autoantibodies vary over time is not known.

Setting

Samples from the national Norwegian Addison's Registry and Biobank established in 1996 (n = 711). Multi-parameter modelling of the course of 21OH-autoantibody indices over time.

Results

21OH-autoantibody positivity is remarkably stable, and >90% of the patients are still positive 30 years after diagnosis. Even though the antibody levels decline with disease duration, it is only rarely that this downturn reaches negativity. 21OH-autoantibody indices are affected by age at diagnosis, sex, type of Addison's disease (isolated vs autoimmune polyendocrine syndrome type I or II) and HLA genotype.

Conclusion

21OH-autoantibodies are reliable and robust markers for autoimmune Addison's disease, linked to HLA risk genotype. However, a negative test in patients with long disease duration does not exclude autoimmune aetiology.

SUBMITTER: Wolff AB 

PROVIDER: S-EPMC8052519 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

The natural history of 21-hydroxylase autoantibodies in autoimmune Addison's disease.

Wolff Anette Boe AB   Breivik Lars L   Hufthammer Karl Ove KO   Grytaas Marianne Aardal MA   Bratland Eirik E   Husebye Eystein Sverre ES   Oftedal Bergithe Eikeland BE  

European journal of endocrinology 20210401 4


<h4>Background</h4>The most common cause of primary adrenal failure (Addison's disease) in the Western world is autoimmunity characterized by autoantibodies against the steroidogenic enzyme 21-hydroxylase (CYP21A2, 21OH). Detection of 21OH-autoantibodies is currently used for aetiological diagnosis, but how levels of 21OH-autoantibodies vary over time is not known.<h4>Setting</h4>Samples from the national Norwegian Addison's Registry and Biobank established in 1996 (n = 711). Multi-parameter mod  ...[more]

Similar Datasets

| S-EPMC4821366 | biostudies-literature
| S-EPMC7250207 | biostudies-literature
| S-EPMC8551825 | biostudies-literature
| S-EPMC4901090 | biostudies-literature
| S-EPMC10110435 | biostudies-literature
| S-EPMC10982488 | biostudies-literature
| S-EPMC4561510 | biostudies-literature
| S-EPMC7853175 | biostudies-literature
| S-EPMC3166911 | biostudies-literature
| S-EPMC5976627 | biostudies-literature